Syntara Limited

A$0.02As of Sun 8 Nov 2026, 12:00 UTC
ASX:SNTHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR (23.68%)
Div yield —
ROE (59.65%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.18
PE TTM —
TSR TTM (40.00%)
Mkt cap A$35.33M
ROIC (364.76%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0188
4.67%
(44.40%)
Hold 0|12|10|4|2
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
4.99%
4.79%
7.21%
14.55%
Revenue$M
4.058
4.132
4.166
4.369
2.00%
1.82%
4.26%
9.01%
Peers (US$24.27M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.055
(0.028)
(0.024)
EBIT/Intx
1.976
0.530
0.534
Own earn%
(48.31)
109.08
104.88
Sh yield%
38.17
36.39
34.93
Owners
Insiders/Inst%
2.86
22.71
Short interest%
1.91
SBC / revenue%
2.54
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
12–15
$1 testx
—
Incr. ROIC%
13